A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: Cannulation of the mesenteric and thoracic lymph ducts within the rat

Journal of Pharmacological and Toxicological Methods

Volumn 49, Issue 2, 2004, Pages 115-120

  Boyd, Michael ^a   Risovic, Verica ^a   Jull, Philip ^a   Choo, Eugene ^a   Wasan, Kishor M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Lymphatic drug delivery; Mesenteric lymph duct; Rat; Surgical procedure; Thoracic lymph duct

Indexed keywords

LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNULATION; DRUG FORMULATION; DRUG TRANSPORT; INTESTINE LYMPH; LYMPH FLOW; LYMPH VESSEL; LYMPHATIC SYSTEM; MALE; MESENTERY LYMPH NODE; NONHUMAN; RAT; SURGICAL TECHNIQUE; THORACIC DUCT;

ANIMALIA; CANIS FAMILIARIS; RATTUS NORVEGICUS; SUS SCROFA;

EID: 1342306882     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2003.11.004     Document Type: Article

References (44)

1. Adachi I., Liu H., Horkoshi I., Ueno M. Possibility of lymphatic absorption of epidermal growth factor from intestine. Yakugaku Zasshi. 113:1993;256-263.
2. Barnwell S.G., Laudanski T., Story M.J., Mallinson C.B., Harris R.J., Cole S.K., Keating M., Attwood D. Improved oral bioavailability of propranolol in healthy human volunteers using a liver bypass drug delivery system containing oleic acid. International Journal of Pharmaceutics. 88:1992;423-432.
3. Borgstrom B., Dahlqvist A., Lundh G., Sjovall J. Studies of intestinal digestion and absorption in the human. Journal of Clinical Investigation. 36:1957;1121-1136.
4. Busbee D.L., Yoo J.-S.H., Norman J.O., Joe C.O. Polychlorinated biphenyl uptake and transport by lymph and plasma components. Proceedings of the Society for Experimental Biology and Medicine. 179:1985;116-122.
5. Carey M.C., Small D.M., Bliss C.M. Lipid digestion and absorption. Annual Review of Physiology. 45:1983;651-677.
6. Chang C.M., Bodmeier R. Binding of drugs to monoglyceride-based drug delivery systems. International Journal of Pharmaceutics. 147:1997;135-142.
7. Charman W.N., Porter C.J.H. Lipophilic prodrugs designed for intestinal lymphatic transport. Advanced Drug Delivery Reviews. 19:1996;149-169.
8. Davidson N.O. Cellular and molecular mechanisms of small intestinal lipid transport. Johnson L.R. Physiology of the gastrointestinal tract. 3rd ed. 1994;1909-1934 Raven Press, New York.
9. Fagerholm U., Johansson M., Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharmaceutical Research. 13:1996;1336-1342.
10. 3H2-alpha-tocopheryl nicotinate in the rat. International Journal for Vitamin and Nutrition Research. 40:1970;505-514.
11. Grimus R.C., Schuster I. The role of the lymphatic transport in the enteral absorption of naftifine by the rat. Xenobiotica. 14:1984;287-294.
12. Hauss D.J., Fogal S.E., Ficorilli J.V. Chronic collection of mesenteric lymph from conscious, tethered rats. Contemporary Topics in Laboratory Animal Science. 37:1998;56-58.
13. 4 inhibitor. Journal of Pharmaceutical Sciences. 87:1998;165-169.
14. Hauss D.J., Mehta S., Radebaugh G.W. Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach. International Journal of Pharmaceutics. 108:1994;85-93.
15. Holm R., Porter C.J., Mullertz A., Kristensen H.G., Charman W.N. Structured triglycerides vehicles for oral delivery of halofantrine: Examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharmaceutical Research. 19:2002;1354-1361.
16. Horst H.J., Holte W.J., Dennis M., Coert A., Geelen J., Voigt K.D. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klinische Wochenschrift. 54:1976;875-879.
17. Humberstone A.J., Porter C.J.H., Charman W.N. A physicochemical basis for the effect of food on the absolute bioavailability of halofantrine. Journal of Pharmaceutical Sciences. 85:1996;525-529.
18. Ichihashi T., Kinoshita H., Shimamura K., Yamada H. Absorption and disposition of epithiosteroids in rats (1): Route of administration and plasma levels of epitiostanol. Xenobiotica. 21:1991;865-872.
19. Ichihashi T., Kinoshita H., Takagishi Y., Yamada H. Intrinsic lymphatic partition rate of mepitiostane, epitiostanol and oleic acid absorbed from rat intestine. Pharmaceutical Research. 8:1991;1302-1306.
20. Ichihashi T., Kinoshita H., Takagishi Y., Yamada H. Effect of bile on absorption of mepitiostane by the lymphatic system in rats. Journal of Pharmacy and Pharmacology. 44:1992;566-569.
21. Ichihashi T., Kinoshita H., Takagishi Y., Yamada H. Effect of oily vehicles on absorption of mepitiostane by the lymphatic system in rats. Journal of Pharmacy and Pharmacology. 44:1992;560-564.
22. Ichihashi T., Kinoshita H., Yamada H. Absorption and disposition of epithiosteroids in rats (2): Avoidance of first-pass metabolism of mepitiostane by lymphatic absorption. Xenobiotica. 21:1991;873-880.
23. Johnson J.M. Triglyceride biosynthesis in the intestinal mucosa. Rommel K., Goebell H., Bohmer R. Lipid absorption: Biochemical and clinical aspects. 1976;85-94 MTP Press, Lancaster.
24. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharmaceutics & Drug Disposition. 16:1995;351-380.
25. Levet-Trafit B., Gruyer M.S., Marjanovic M., Chou R.C. Estimation of oral drug absorption in man based on intestine permeability in rats. Life Sciences. 58:1996;PL359-PL363.
26. Liu H.-X., Adachi I., Horkoshi I., Ueno M. Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane. International Journal of Pharmaceutics. 118:1995;55-64.
27. Pahl M.V., Oveisi F., Khamiseh G., Vaziri N.D. Intestinal absorption and biliary secretion of cholesterol in rats with nephrotic syndrome. Nephrology, Dialysis, Transplantation. 13:1998;1446-1451.
28. Palin K.J., Wilson C.J. The effect of different oils on the absorption of probucol in the rat. Journal of Pharmacy and Pharmacology. 36:1984;641-643.
29. Porter C.J.H., Charman S.A., Charman W.N. Lymphatic transport of halofantrine in the triple-cannulated anaesthetized rat model: Effect of lipid vehicle dispersion. Journal of Pharmaceutical Sciences. 85:1996;351-356.
30. Porter C.J.H., Charman W.N. Uptake of drugs into the intestinal lymphatics after oral administration. Advanced Drug Delivery Reviews. 25:1997;71-89.
31. Porter C.J.H., Charman W.N. Intestinal lymphatic drug transport: An update. Advanced Drug Delivery Reviews. 50(1-2):2001;61-80.
32. Shah N.H., Carvajal M.T., Patel C.I., Infeld M.H., Malick A.W. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. International Journal of Pharmaceutics. 106:1994;15-23.
33. Shiau Y.-F. Mechanism of intestinal fat absorption. American Journal of Physiology. 240:1981;G1-G9.
34. Soria I., Zimmerman C.L. The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. Biopharmaceutics & Drug Disposition. 17:1996;817-818.
35. Sugihara J., Furuuchi S. Lymphatic absorption of hypolipidemic compound 1-O-[p-(myristyloxy)-alpha-methylcinnamoyl]glycerol (LK-903). Journal of Pharmacobio-Dynamics. 11:1988;121-130.
36. Sugihara J., Furuuchi S., Ando H., Takashima K., Harigaya S. Studies on the intestinal lymphatic absorption of drugs: II. Glyceride prodrugs for improving the lymphatic absorption of naproxen and nicotinic acid. Journal of Pharmacobio-Dynamics. 11:1988;555-562.
37. Thomson A.B.R., Keelan M., Garg M.L., Clandinin M.T. Intestinal aspects of lipid absorption: In review. Canadian Journal of Physiology and Pharmacology. 67:1989;179-191.
38. Thomson A.B., Schoeller C., Keelan M., Smith L., Clandinin M.T. Lipid absorption: Passing through the unstirred layers, brush border membrane, and beyond. Canadian Journal of Physiology and Pharmacology. 71:1993;531-555.
39. Tso P. Intestinal lipid absorption. Johnson L.R. Physiology of the gastrointestinal tract. 1994;1867-1908 Raven Press, New York.
40. Tucker G. Drug Delivery: Lymphing along? Lancet. 341:1993;1314-1315.
41. Ueda C.T., Lemaire M., Gsell G., Nussbaumer K. Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution to rats. Biopharmaceutics & Drug Disposition. 4:1983;113-124.
42. Wasan K.M. The role of lymphatic transport in enhancing oral protein and peptide drug delivery. Drug Development and Industrial Pharmacy. 28:2002;1047-1058.
43. Wasan K.M., Ramaswamy M., McIntosh M.P., Porter C.J., Charman W.N. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: In vitro studies in normolipidemic and dyslipidemic human plasmas. Journal of Pharmaceutical Sciences. 88:1999;185-190.
44. White D.G., Story M.J., Barnwell S.G. An experimental animal model for studying the effects of a novel lymphatic drug delivery system for propranolol. International Journal of Pharmaceutics. 69:1991;169-174.